Quincy, MA, United States of America

Vishal Saxena

USPTO Granted Patents = 2 


 

Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 12(Granted Patents)


Company Filing History:


Years Active: 2015-2018

Loading Chart...
Loading Chart...
Loading Chart...
2 patents (USPTO):

Title: Vishal Saxena: Innovator in Pharmaceutical Chemistry

Introduction

Vishal Saxena is a notable inventor based in Quincy, MA (US). He has made significant contributions to the field of pharmaceutical chemistry, holding a total of 2 patents. His work focuses on innovative processes and compositions that have the potential to impact medical treatments.

Latest Patents

Vishal Saxena's latest patents include the invention of salts of 7-cyclopentyl-2-(5-piperazin-1-yl-pyridin-2-ylamino)-7H-pyrrolo[2,3-d]pyrimidine-6-carboxylic acid dimethylamide. This invention encompasses several key aspects: (1) the process of making 7-Cyclopentyl-2-(5-piperazin-1-yl-pyridin-2-ylamino)-7H-pyrrolo[2,3-d]pyrimidine-6-carboxylic acid dimethylamide and its salts; (2) novel salts of the compound; (3) pharmaceutical compositions that include these salts; and (4) methods of treatment utilizing these compositions.

Career Highlights

Throughout his career, Vishal Saxena has worked with prominent companies in the pharmaceutical industry, including Novartis AG and Astex Therapeutics Limited. His experience in these organizations has allowed him to develop and refine his innovative ideas in drug development.

Collaborations

Vishal has collaborated with esteemed colleagues such as John Vincent Calienni and Guang-Pei Chen. These partnerships have contributed to the advancement of his research and the successful development of his patents.

Conclusion

Vishal Saxena is a distinguished inventor whose work in pharmaceutical chemistry continues to pave the way for new treatments and innovations. His contributions are significant in the realm of drug development and medical applications.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…